At BIO 2026, industry wrestled with Washington politics, and making AI work better
By
Brittany Trang, Daniel Payne
12d ago· 3 min readNews
Source
bskyAt BIO 2026, industry wrestled with Washington politics, and making AI work betterstatnews.comBiotech executives reveal concerns over Chinese biotech, the profitability of AI, and the durability of Trump's drug price moves.
You might also wanna read
The times they are a-changin’: Washington suddenly warms to regulating AI
FORTUNE·1mo ago
AI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
The Verge·1mo agoAI industry leaders unite to urge US lawmakers on bioweapon safeguards
AI industry rivals including Anthropic's Dario Amodei, OpenAI's Sam Altman, and Microsoft's Mustafa Suleyman have united in an open letter t
theverge.com·1mo ago
STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned
STAT·2d ago
STAT+: Four major biotech updates to catch up on
STAT·2d ago
The case for bioliteracy: Exploring biotech’s role in national security
bioprocessintl.com·22d ago
White House Releases National AI Bill Framework as Project 2025 Splinter Group Challenges AI Industry
The article discusses the intersection of technology, politics, and regulation, focusing on two major tech news developments: the White Hous
The Verge·3mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.